piperlongumine, 20069-09-4

Articles:

PubMed:	Dealing Naturally with Stumbling Blocks on Highways and Byways of TRAIL Induced Signaling.
PubMed:	Piperlongumine-induced phosphatidylserine translocation in the erythrocyte membrane.
PubMed:	Impact of DNA repair pathways on the cytotoxicity of piperlongumine in chicken DT40 cell-lines.
PubMed:	Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer.
PubMed:	Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
PubMed:	Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents (review).
PubMed:	Piperlongumine Chemosensitizes Tumor Cells through Interaction with Cysteine 179 of IκBα Kinase, Leading to Suppression of NF-κB-Regulated Gene Products.
PubMed:	Targeting antioxidants for cancer therapy.
PubMed:	Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells.
PubMed:	Piperlongumine inhibits migration of glioblastoma cells via activation of ROS-dependent p38 and JNK signaling pathways.
PubMed:	Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents.
PubMed:	Piperlongumine induces apoptosis and synergizes with cisplatin or paclitaxel in human ovarian cancer cells.
PubMed:	Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates endoplasmic reticulum stress, and preferentially kills high-grade glioma cells.
PubMed:	Anticancer principles from medicinal piper ( hú jiāo) plants.
PubMed:	Piperlongumine as a potential activator of AMP-activated protein kinase in HepG2 cells.
PubMed:	Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
PubMed:	Radio-sensitization by Piper longumine of human breast adenoma MDA-MB-231 cells in vitro.
PubMed:	Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells.
PubMed:	Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer.
PubMed:	Biodegradable nanoassemblies of piperlongumine display enhanced anti-angiogenesis and anti-tumor activities.
PubMed:	Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death.
PubMed:	Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate.
PubMed:	Synthesis of piperlogs and analysis of their effects on cells.
PubMed:	Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells.
PubMed:	Piperlongumine induces autophagy by targeting p38 signaling.
PubMed:	Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.
PubMed:	An improved quantitative approach for the assessment of mitochondrial fragmentation in chemoresistant ovarian cancer cells.
PubMed:	Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation.
PubMed:	ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors.
PubMed:	Piperlongumine inhibits LMP1/MYC-dependent mouse B-lymphoma cells.
PubMed:	Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century.
PubMed:	Activation of ERK signaling and induction of colon cancer cell death by piperlongumine.
PubMed:	Discovery of small-molecule enhancers of reactive oxygen species that are nontoxic or cause genotype-selective cell death.
PubMed:	Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells.
PubMed:	Overview of the therapeutic potential of piplartine (piperlongumine).
PubMed:	Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro.
PubMed:	Piperlongumine inhibits atherosclerotic plaque formation and vascular smooth muscle cell proliferation by suppressing PDGF receptor signaling.
PubMed:	Quantitative microtiter fibronectin fibrillogenesis assay: use in high throughput screening for identification of inhibitor compounds.
PubMed:	Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs.
PubMed:	Specific 5-hydroxylation of piperlongumine by Beauveria bassiana ATCC 7159.
PubMed:	A novel flow cytometric HTS assay reveals functional modulators of ATP binding cassette transporter ABCB6.
PubMed:	Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells.
PubMed:	Selective killing of cancer cells by a small molecule targeting the stress response to ROS.
PubMed:	Overview for various aspects of the health benefits of Piper longum linn. fruit.
PubMed:	Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity.
PubMed:	Antiplatelet activities of newly synthesized derivatives of piperlongumine.
PubMed:	Antiplatelet effects of acidamides isolated from the fruits of Piper longum L.
PubMed:	Piperlongumine, a constituent of Piper longum L., inhibits rabbit platelet aggregation as a thromboxane A(2) receptor antagonist.
PubMed:	Suppression of ochratoxin biosynthesis by naturally occurring alkaloids.
PubMed:	Amides from Piper nigrum L. with dissimilar effects on melanocyte proliferation in-vitro.
PubMed:	A piperidine amide extracted from Piper longum L. fruit shows activity against Aedes aegypti mosquito larvae.
PubMed:	Alkaloids of Piper longum Linn. I. Structure and synthesis of piperlongumine and piperlonguminine.